Secobarbital

Table of contents

  • Brand Names
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Pregnancy and Lactation Implications
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Genes that may be involved
  • Induces
  • Drug Interactions
  • Nutrition/Nutraceutical Interactions
  • Dosage
  • Pharmacokinetics and Pharmacodynamics
  • Special Considerations

Brand Names

North America

USA: Seconal Sodium.

Asia

Japan: Ional Sodium.

Drug combinations

Chemistry

Secobarbital: C~12~H~18~N~2~O~3~. Mw: 238.28. (1) 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-; (2) 5-Allyl-5-(1-methylbutyl)barbituric acid. CAS-76-73-3.

Secobarbital Sodium: C~12~H~17~N~2~NaO~3~. Mw: 260.26. (1) 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, monosodium salt; (2) Sodium 5-allyl-5-(1-methylbutyl)barbiturate. CAS-309-43-3.

Pharmacologic Category

Anxiolytics, Sedatives, and Hypnotics; Barbiturates. (ATC-Code: N05CA06).

Mechanism of action

Depresses CNS activity by binding to barbiturate site at GABA-receptor complex enhancing GABA activity, depressing reticular activity system (higher doses may be gabamimetic).

Therapeutic use

Preanesthetic agent. Short-term treatment of insomnia.

Pregnancy and lactiation implications

Pregnancy should be avoided while taking this medication. Enters breast milk (use caution).

Unlabeled use

Contraindications

Hypersensitivity to barbiturates or any component of the formulation. Marked hepatic impairment. Dyspnea or airway obstruction. Porphyria. Pregnancy.

Warnings and precautions

May cause CNS depression. Postmarketing studies indicated that use of hypnotic/sedative agents for sleep has been associated with hypersensitivity reactions including anaphylaxis as well as angioedema. May cause paradoxical responses, including agitation and hyperactivity, particularly in acute pain, chronic pain and pediatric patients. Increased risk for hazardous sleep-related activities such as sleep-driving; cooking and eating food, and making phone calls while asleep also noted. Use with caution in cardiovascular disease (may cause hypotension), in depression or suicidal tendencies, and in history of drug abuse or acute alcoholism (risk of drug dependency). Tolerance, psychological and physical dependence may occur with prolonged use. Use with caution in hepatic/renal impairment, and in respiratory disease (may cause respiratory depression). Effects may be potentiated when used with other sedative drugs or ethanol. Use with caution in the elderly, and in children. Abrupt cessation may precipitate withdrawal symptoms, including status epilepticus in epileptic patients.

Information

Legal

Legal Notice
Privacy Policy
Cookie Policy

Contact

Phone: +34-981-780505
Email: genomicmedicine@wagem.org
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart